2020 AISF/SIMTI意见书:肝硬化患者白蛋白的合理应用

2020-12-18 意大利肝病学会 Blood Transfus . 2020 Dec 18.

2020年,意大利肝病学会(AISF)联合意大利输血医学及免疫血液学会(SIMTI)共同发布了肝硬化患者白蛋白的合理应用的意见书。本文是对2016年肝硬化患者白蛋白的合理应用意见书的更新。

中文标题:

2020 AISF/SIMTI意见书:肝硬化患者白蛋白的合理应用

英文标题:

AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update

发布机构:

意大利肝病学会

发布日期:

2020-12-18

简要介绍:

2020年,意大利肝病学会(AISF)联合意大利输血医学及免疫血液学会(SIMTI)共同发布了肝硬化患者白蛋白的合理应用的意见书。本文是对2016年肝硬化患者白蛋白的合理应用意见书的更新。

 

评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191940, encodeId=f99811919405b, content=转走, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Feb 10 18:22:08 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061888, encodeId=9df8106188892, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:39:39 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016421, encodeId=32f4101642131, content=下一次之后能分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/06e9c0d78bfd4893b14902966e1261ec/f1b6a740567e43c1ac62ff3560f2d436.jpg, createdBy=2f8b1998595, createdName=猫咪猪旺旺, createdTime=Fri Sep 10 22:46:06 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003616, encodeId=c27e100361664, content=积分任务, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Jul 29 16:21:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002949, encodeId=56f310029494c, content=咋下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec945454019, createdName=ms5000001396549113, createdTime=Tue Jul 27 10:34:27 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2022-02-10 ms7000001442489548

    转走

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191940, encodeId=f99811919405b, content=转走, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Feb 10 18:22:08 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061888, encodeId=9df8106188892, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:39:39 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016421, encodeId=32f4101642131, content=下一次之后能分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/06e9c0d78bfd4893b14902966e1261ec/f1b6a740567e43c1ac62ff3560f2d436.jpg, createdBy=2f8b1998595, createdName=猫咪猪旺旺, createdTime=Fri Sep 10 22:46:06 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003616, encodeId=c27e100361664, content=积分任务, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Jul 29 16:21:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002949, encodeId=56f310029494c, content=咋下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec945454019, createdName=ms5000001396549113, createdTime=Tue Jul 27 10:34:27 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-10-19 湘雅科教

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191940, encodeId=f99811919405b, content=转走, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Feb 10 18:22:08 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061888, encodeId=9df8106188892, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:39:39 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016421, encodeId=32f4101642131, content=下一次之后能分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/06e9c0d78bfd4893b14902966e1261ec/f1b6a740567e43c1ac62ff3560f2d436.jpg, createdBy=2f8b1998595, createdName=猫咪猪旺旺, createdTime=Fri Sep 10 22:46:06 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003616, encodeId=c27e100361664, content=积分任务, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Jul 29 16:21:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002949, encodeId=56f310029494c, content=咋下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec945454019, createdName=ms5000001396549113, createdTime=Tue Jul 27 10:34:27 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-09-10 猫咪猪旺旺

    下一次之后能分享吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191940, encodeId=f99811919405b, content=转走, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Feb 10 18:22:08 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061888, encodeId=9df8106188892, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:39:39 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016421, encodeId=32f4101642131, content=下一次之后能分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/06e9c0d78bfd4893b14902966e1261ec/f1b6a740567e43c1ac62ff3560f2d436.jpg, createdBy=2f8b1998595, createdName=猫咪猪旺旺, createdTime=Fri Sep 10 22:46:06 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003616, encodeId=c27e100361664, content=积分任务, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Jul 29 16:21:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002949, encodeId=56f310029494c, content=咋下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec945454019, createdName=ms5000001396549113, createdTime=Tue Jul 27 10:34:27 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-07-29 ms7000001442489548

    积分任务

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191940, encodeId=f99811919405b, content=转走, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Feb 10 18:22:08 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061888, encodeId=9df8106188892, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Tue Oct 19 16:39:39 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016421, encodeId=32f4101642131, content=下一次之后能分享吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/06e9c0d78bfd4893b14902966e1261ec/f1b6a740567e43c1ac62ff3560f2d436.jpg, createdBy=2f8b1998595, createdName=猫咪猪旺旺, createdTime=Fri Sep 10 22:46:06 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003616, encodeId=c27e100361664, content=积分任务, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77785342622, createdName=ms7000001442489548, createdTime=Thu Jul 29 16:21:55 CST 2021, time=2021-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002949, encodeId=56f310029494c, content=咋下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec945454019, createdName=ms5000001396549113, createdTime=Tue Jul 27 10:34:27 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-07-27 ms5000001396549113

    咋下载

    0

拓展阅读

AASLD成人肝硬化腹水治疗指南2012年修订版

美国肝病研究学会(AASLD,American Association for the Study of Liver Diseases) · 2013-04-08

肝硬化门静脉高压食管胃静脉曲张出血的防治指南

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-06-02

2015年多学科专家共识:危重患者肝硬化的管理

美国移植学会(AST,American Society of Transplantation) · 2016-06-02

2016年AISF/SIMTI意见书:肝硬化患者合理使用白蛋白

意大利肝病学会(AISF,Italian Association for the Study of the Liver) · 2016-06-02

原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015)

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-06-02